Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Cambrex Threatened with Delisting from NYSE
7:19 AM MDT | April 15, 2009 | Alex Scott
Cambrex, one of the best known U.S. contract fine chemical manufacturers, has disclosed that it has received notification from the New York Stock Exchange (NYSE) that its listing on the exchange is under threat because its market capitalization has dipped below $75 million. NYSE rules stipulate that listed companies must have a market capitalization of more than $75 million over a consecutive 30-day trading period. Cambrex reported a market capitalization of $74.8 million as of December 31, 2008. The company says that within the next 45...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee